21324184

Source:http://linkedlifedata.com/resource/pubmed/id/21324184

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0013216, umls-concept:C0030705, umls-concept:C0034380, umls-concept:C0034656, umls-concept:C0205179, umls-concept:C0205390, umls-concept:C0278488, umls-concept:C0332174, umls-concept:C1274040, umls-concept:C1280500, umls-concept:C1517927
pubmed:dateCreated	2011-3-9
pubmed:databankReference	http://linkedlifedata.com/resource/pubmed/xref/ClinicalTrials.gov/NCT00540800
pubmed:abstractText	To evaluate whether weekly schedules of docetaxel-based chemotherapy were superior to 3-weekly ones in terms of quality of life in locally advanced or metastatic breast cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-10334526, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-10561296, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-10615229, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-10715290, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-10883663, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-11481356, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-11896092, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-11920456, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-12039922, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-12065558, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-12172982, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-12637459, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-14559892, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-15241840, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-15319242, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-16192591, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-1654074, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-18160303, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-18300256, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-18375893, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-18420499, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-7912725, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-8433390, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-8523050, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-8523051, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-8889347, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-9563897, http://linkedlifedata.com/resource/pubmed/commentcorrection/21324184-9626217
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100967800
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/capecitabine, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status	MEDLINE
pubmed:issn	1471-2407
pubmed:author	pubmed-author:BottiGerardoG, pubmed-author:D'AiutoGiuseppeG, pubmed-author:De MaioErmelindaE, pubmed-author:Di BonitoMaurizioM, pubmed-author:Di MaioMassimoM, pubmed-author:Di RellaFrancescaF, pubmed-author:GalloCiroC, pubmed-author:GravinaAdrianoA, pubmed-author:LaboniaVincenzoV, pubmed-author:LandiGabriellaG, pubmed-author:MorabitoAlessandroA, pubmed-author:NuzzoFrancescoF, pubmed-author:PacilioCarmenC, pubmed-author:PerroneFrancescoF, pubmed-author:PiccirilloMaria CarmelaMC, pubmed-author:RinaldoMassimoM, pubmed-author:RossiEmanuelaE, pubmed-author:ThomasRenatoR, pubmed-author:de MatteisAndreaA
pubmed:issnType	Electronic
pubmed:volume	11
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	75
pubmed:dateRevised	2011-7-26
pubmed:meshHeading	pubmed-meshheading:21324184-Adult, pubmed-meshheading:21324184-Aged, pubmed-meshheading:21324184-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21324184-Breast Neoplasms, pubmed-meshheading:21324184-Deoxycytidine, pubmed-meshheading:21324184-Disease Progression, pubmed-meshheading:21324184-Drug Administration Schedule, pubmed-meshheading:21324184-Epirubicin, pubmed-meshheading:21324184-Female, pubmed-meshheading:21324184-Fluorouracil, pubmed-meshheading:21324184-Humans, pubmed-meshheading:21324184-Middle Aged, pubmed-meshheading:21324184-Neoplasm Metastasis, pubmed-meshheading:21324184-Quality of Life, pubmed-meshheading:21324184-Taxoids
pubmed:year	2011
pubmed:articleTitle	Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial.
pubmed:affiliation	National Cancer Institute, via M, Semmola, 80131 Napoli, Italy.
pubmed:publicationType	Journal Article, Randomized Controlled Trial

More...